Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Genvresse

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The British Journal of Dermatology|December 21, 2000
Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbineI Genvresse, B Flath, K Akrivakis, et al.
Deutsche Medizinische Wochenschrift (1946)|May 18, 1999
[Primary cerebral highly-malignant B-cell lymphoma of the Burkitt type]E Späth-Schwalbe, I Genvresse, H Stein, et al.
Anti-Cancer Drugs|May 4, 2001
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative studyI Genvresse, C Lange, J Schanz, et al.
Bone Marrow Transplantation|March 14, 2003
Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achievedG Massenkeil, M Nagy, M Lawang, et al.
British Journal of Cancer|January 20, 2018
Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancerR D Kim, S R Alberts, C Peña, et al.
Leukemia|October 17, 2003
Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CMLP le Coutre, K A Kreuzer, G Massenkeil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The British Journal of Dermatology|December 21, 2000
Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbineI Genvresse, B Flath, K Akrivakis, et al.
Deutsche Medizinische Wochenschrift (1946)|May 18, 1999
[Primary cerebral highly-malignant B-cell lymphoma of the Burkitt type]E Späth-Schwalbe, I Genvresse, H Stein, et al.
Anti-Cancer Drugs|May 4, 2001
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative studyI Genvresse, C Lange, J Schanz, et al.
Bone Marrow Transplantation|March 14, 2003
Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achievedG Massenkeil, M Nagy, M Lawang, et al.
British Journal of Cancer|January 20, 2018
Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancerR D Kim, S R Alberts, C Peña, et al.
Leukemia|October 17, 2003
Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CMLP le Coutre, K A Kreuzer, G Massenkeil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
Pageof 2